Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis

New Zealand Respiratory and Sleep Institute, Greenlane

Royal Prince Alfred Hospital, Camperdown

UZ Leuven, Leuven

The Alfred Hospital, Melbourne

Catharina Ziekenhuis, Eindhoven

Canisius-Wilhelmina Ziekenhuis, Nijmegen

University of Otago Christchurch, Christchurch

UPMC, Pittsburgh

San Giuseppe Hospital, Multimedica S.p.a., Milan

PulmonIx, Greensboro

The Emory Clinic, Atlanta

Vanderbilt Lung Institute at One Hundred Oaks, Nashville

Baylor College of Medicine, Houston

Pulmonary Associates, PA, Phoenix

Cedars-Sinai Medical Center, Interstitial Lung Disease Program, Pulmonary and Critical Care Medicine, Los Angeles

Yale University Scool of Medicine/ Yale New Haven Hospital, New Haven

Brigham and Women's Hospital, Boston

Cardio-Pulmonary Associates of St. Luke's Hospital - Chesterfield, Chesterfield

Dr. Anil Dhar Medicine Professional Corporation, Windsor

CISSS de la Montérégie Centre, Greenfield Park